CLEVELAND BIOLABS INC·4

May 21, 9:02 PM ET

SALUCK RANDY S. 4

4 · CLEVELAND BIOLABS INC · Filed May 21, 2013

Insider Transaction Report

Form 4
Period: 2013-05-17
Transactions
  • Purchase

    Common Stock, par value $0.005 per share

    2013-05-17$1.60/sh+3,500$5,61384,500 total(indirect: Held by Mortar Rock L.P.)
Footnotes (1)
  • [F1]Mr. Saluck is a managing member of Mortar Rock Capital Management, LLC, which manages Mortar Rock L.P.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES